Picture of Thomson Medical logo

A50 — Thomson Medical Cashflow Statement

0.000.00%
sg flag iconLast trade - 00:00
HealthcareAdventurousMid CapMomentum Trap

Annual cashflow statement for Thomson Medical, fiscal year end - June 30th, SGD millions except per share, conversion factor applied.

2022
June 30th
2023
June 30th
2024
June 30th
2025
June 30th
2026
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line69.355.230.6-40.6-21.1
Depreciation
Amortisation
Non-Cash Items21.928.718.876.661.1
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-16.3-16.46.46-14.2-9.98
Change in Accounts Receivable
Change in Inventories
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities92.888.683.360.471
Capital Expenditures-27.8-11.2-26.9-22.6-15.3
Purchase of Fixed Assets
Other Investing Cash Flow Items-1.68-2.18-463-4.58-4.43
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Change in Net Intangibles
Cash from Investing Activities-29.4-13.4-490-27.2-19.7
Financing Cash Flow Items-23.3-32.3-58.6-58-47.1
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-23.554.2281-71.2-62.7
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash38.8125-126-36.2-8.91